CGCNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends March 31

Canopy Growth Corp

Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026

$0.72+0.00 (+0.38%)

Close on Oct 19, 2026

Canopy Growth Corp income statement

Annual Quarterly TTM

CAD USD

Millions of CAD, except per-share data. Shares in millions.

Line item	FY 2026 2026-03-31	FY 2025 2025-03-31	FY 2024 2024-03-31	FY 2023 2023-03-31	FY 2022 2022-03-31	FY 2021 2021-03-31	FY 2020 2020-03-31	FY 2019 2019-03-31	FY 2018 2018-03-31	FY 2017 2017-03-31
Revenue	285	269	297	333	476	547	399	226	78	40
Cost of Revenue	215	189	216	397	663	480	430	198	45	–
Gross Profit	70	80	81	-64	-187	67	-32	28	33	39
Research & Development	2.61	2.74	4.61	22	32	58	62	15	2.05	0.81
Selling, General & Admin	160	170	229	343	415	575	694	392	103	15
Selling & Marketing	–	–	–	–	–	–	–	154	38	13
General & Administrative	–	–	–	–	–	–	–	–	6.45	1.99
Advertising Expenses	26	23	29	28	53	72	78	57	1.04	2.31
Operating Expenses	231	197	310	2,567	831	1,310	1,637	666	153	53
Operating Income	-162	-117	-229	-2,631	-1,019	-1,243	-1,669	-637	-120	-14
Interest Expense	38	75	105	126	104	8.46	6.72	2.04	0.78	–
Income from Equity Investments	–	–	–	–	-0.10	-53	-64	-11	-1.47	-0.05
Other Non-Operating Income	-101	-391	-279	-456	751	-388	224	-60	70	–
Merger & Restructuring Charges	67	31	66	2,257	369	534	623	0	–	–
Asset Impairment Charges	47	–	42	1,728	41	0	–	–	28	–
Gain (Loss) on Sale of Assets	–	–	–	–	16	–	–	–	–	–
Pretax Income	-263	-508	-508	-3,086	-268	-1,684	-1,509	-708	-51	-10
Income Tax Expense	0.02	7.14	12	-5.73	-8.95	-13	-122	4.11	-0.39	-2.70
Income from Continuing Operations	-263	-515	-520	-3,080	-259	–	–	–	–	–
Income from Discontinued Operations	0	6.02	-192	-229	-72	–	–	–	–	–
Net Income incl. Noncontrolling Interests	-263	-509	-712	-3,310	-331	-1,671	-1,387	-712	-51	-7.57
Minority Interest in Earnings	–	–	–	-1.90	-4.37	74	-66	24	16	-0.05
Net Income	-263	-509	-694	-3,278	-310	-1,745	-1,321	-736	-67	–
EPS (Basic)(per share)	-0.88	-4.73	-9.27	-70.69	-7.92	-46.90	-38.00	-27.60	-3.80	-0.60
EPS (Diluted)(per share)	-0.88	-4.73	-9.27	-70.69	-7.92	-46.90	-38.00	-27.60	-3.80	-0.60
Shares Outstanding (Basic, Weighted)(shares)	298	108	75	46	39	37	35	27	18	12
Shares Outstanding (Diluted, Weighted)(shares)	298	108	75	46	39	37	35	27	18	12
EBITDA	–	–	–	–	–	–	–	-616	-107	-8.02
Net Interest Income	–	–	–	–	-9.57	–	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 25.2%
Operating margin: -54.9%
Net margin: -79.2%
Return on equity, FY2026: -44.7%

Financial strength

Current ratio: 3.04
Debt to equity: –
Debt to assets: 21.8%
Cash to current liabilities: 201.9%

Valuation

P/E ratio: –
Price to sales: –
Price to book: –
Dividend yield: –

Valuation ratios need the share price and fill in once daily prices are connected.